recall
saveGlenmark Pharmaceuticals Inc., USA recall (Cls II)
community read0 votes
Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-270-30. — Reason: CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Status: Ongoing
view source ↗Data sources
last refreshed 44m ago
Found something off?
same company · ±60 days · 6
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Feb 26, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Feb 26, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Feb 26, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Feb 26, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Feb 26, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Feb 26, 2025
comments(0)
5-min edit window · permanent after that